Document is current

Any future updates will be listed below

Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications

Crossref DOI link: https://doi.org/10.1186/s13046-025-03423-6

Published Online: 2025-05-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark